Use access key #2 to skip to page content.
$19.91 0.12 (0.61%)
5/12/2008 4:00 PM

Pfizer, Inc. (PFE)

CAPS Rating:
***

A research-based, pharmaceutical Company which discovers, develops, manufactures and markets prescription medicines for humans and animals.

Rating a stock in CAPS consists of three components:

Your call - Will this stock outperform or underperform the S&P 500? Successful picks are measured in terms of whether or not you were correct and by how many percentage points.

Your time frame - A guideline for other players to see whether your thinking is short or long-term. Time frame is also used to calculate the stock rating, but is not used in the scoring of your pick.

Your pitch - Here's your chance to offer more detailed thoughts, analysis, concerns, or the rationale behind your call. The pitch is optional and may be added later.

Each time you rate a stock, CAPS updates the community intelligence for the company, which may or may not change its CAPS rating. For more information, visit the Help tab at the top of the page.

You aren't currently rating PFE

Add Stock to Watchlist

Pfizer, Inc. At A Glance

Current Price: $19.91
Last Trade Time: 5/12/2008 4:00 PM
Open: $0.00
Previous Close: $19.79
Daily Range: $19.78 - $19.97
52-Week Range: $19.70 - $27.73
Volume: 36,108,992
Market Cap: $133.88B
P/E Ratio: 17.67
Compare Our Special Broker Offers!

Stock Trends

PFE VS S&P 500 (SPY)

PFE 12 month chart vs. S&P

News & Discussion Boards

Other News Headlines for PFE

More Headlines...

Top Bull Pitch

Recs

7

Pfizer, Inc. (PFE)

Avatar xthecritic (69.20) Submitted: 2/06/08 1:41 PM

This is a sector play. Drug manufacturers have been and will continue to outperform the market in the next 12-18 months as we deal with economic weakness. I like the sector overall after several years of pressure from products coming off patent and with positive overall demographic trends.

Pfizer i...More

Replies: 0 | Reply | Permalink

Top Bear Pitch

Recs

7

Pfizer, Inc. (PFE)

Avatar hp52ca (99.28) Submitted: 11/20/07 4:18 PM

My small investment club has owned this stock for 4-1/2 years ... an IRR (internal rate of return - meaning annual) of about -5% (that's MINUS 5%) even with reinvested dividends. Maybe it will recover - it has a great financial strength, etc. - but it's been dead money for us for nigh on five yea...More

Replies: 2 | Reply | Permalink

CAPS Players

picks per page. CHANGE

Results 1 - 5 of 664 :   1 2 3 4 5 Next » Jump to page:

Show Pitch Replies

Recs

0

 (PFE)

Avatar oracleofboca (24.57) Submitted: 5/10/08 1:33 AM : Outperform Start Price: $19.85 PFE Score: -0.57

Big pharma has been in a bear market for years. Just about everyone and his brother has thrown in the toel on Pfizer, yet its moat is much wider than most investors realize.

Report this Post Replies: 0 | Reply | Permalink

Recs

1

 (PFE)

Avatar mukwonago53149 (78.18) Submitted: 5/08/08 12:19 AM : Outperform Start Price: $19.98 PFE Score: -0.83

Here's a stock that's on sale now! You can buy Pfizer today at the price it was selling for a decade ago PLUS it comes with a huge juicy dividend! With a market cap of over $130 Billion, Pfizer is an established brand that can stand the test of time. The odds of this company going bankrupt are very low - people need their medication.

Report this Post Replies: 1 | Reply | Permalink

Recs

0

 (PFE)

Avatar jdolemissrebel (41.84) Submitted: 5/07/08 12:17 PM : Outperform Start Price: $19.97 PFE Score: 0.23

Great dividend, good liquidity, cheap stock.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (PFE)

Avatar stuatror (36.51) Submitted: 5/07/08 11:21 AM : Outperform Start Price: $19.98 PFE Score: 0.37

Its so low it's got to go up. I'm buying more.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (PFE)

Avatar jc09058 (29.27) Submitted: 5/07/08 9:51 AM : Underperform Start Price: $20.16 PFE Score: 0.29

While this is a great stock as far as dividend payments go, I do not see anything in the immediate future to boost it's stock price. Nothing has been released, news wise, that would indicate the finish on testing or development of a new 'wonder' drug from Pfizer. Yet, with all of the money available to them, I am left wondering what they are planning for the future.

I bought this stock very cheap years ago and have been satisfied with the past results. As to whether I would purchase more now that it is cheaper, I am not sure yet. For now, I will hold on to it as long as dividends don't start to drop.

Report this Post Replies: 0 | Reply | Permalink

Results 1 - 5 of 664 :   1 2 3 4 5 Next » Jump to page:

Wall Street

Results 1 - 21 of 21  

picks per page. CHANGE Expand All Pitches

Top
Pick
Player NamePlayer RatingStart
Date
CallTime FrameStart
Price
Stock
Gain
S&P
Gain
ScorePitch
TrackPatDorsey 75.43 01/25/08 Outperform 5Y $21.95-9.30%+5.58%-14.88
TrackSoros < 20 09/30/07 Outperform NS $23.43-15.03%-7.94%-7.08 Toggle the visibility of 60-Second Pitch and replies
TrackDreman 94.45 09/30/07 Outperform NS $23.43-15.03%-7.94%-7.08 Toggle the visibility of 60-Second Pitch and replies
TrackEveillard 86.50 09/30/07 Outperform NS $23.43-15.03%-7.94%-7.08 Toggle the visibility of 60-Second Pitch and replies
TrackDodgeCox 93.10 09/30/07 Outperform NS $23.43-15.03%-7.94%-7.08 Toggle the visibility of 60-Second Pitch and replies
TrackBrandes < 20 09/30/07 Outperform NS $23.43-15.03%-7.94%-7.08 Toggle the visibility of 60-Second Pitch and replies
TrackNWQ 29.20 09/30/07 Outperform NS $23.43-15.03%-7.94%-7.08 Toggle the visibility of 60-Second Pitch and replies
TrackRichPzena < 20 09/30/07 Outperform NS $23.43-15.03%-7.94%-7.08 Toggle the visibility of 60-Second Pitch and replies
TrackHAndW < 20 09/30/07 Outperform NS $23.43-15.03%-7.94%-7.08 Toggle the visibility of 60-Second Pitch and replies
TrackSnow 81.11 09/30/07 Outperform NS $23.43-15.03%-7.94%-7.08 Toggle the visibility of 60-Second Pitch and replies
TrackEdwardOwens 71.22 09/30/07 Outperform NS $23.43-15.03%-7.94%-7.08 Toggle the visibility of 60-Second Pitch and replies
TrackVanDenBerg < 20 09/30/07 Outperform NS $23.43-15.03%-7.94%-7.08 Toggle the visibility of 60-Second Pitch and replies
TrackHillman 39.06 09/30/07 Outperform NS $23.43-15.03%-7.94%-7.08 Toggle the visibility of 60-Second Pitch and replies
TrackBRogers 83.04 09/30/07 Outperform NS $23.43-15.03%-7.94%-7.08 Toggle the visibility of 60-Second Pitch and replies
TrackScottBleier < 20 08/31/07 Outperform 3M $23.82-16.43%-4.83%-11.60
Track2007Wired40 97.97 03/27/07 Underperform 1Y $23.90-16.71%-1.68%+15.03
TrackMichaelSivy 53.58 03/20/07 Outperform 1Y $23.61-15.68%-0.36%-15.32
TrackDeutscheSec 89.43 12/04/06 Outperform NS $21.94-9.25%+0.15%-9.40
TrackJimCramer 81.00 09/25/06 Underperform 3W $26.30-24.29%+5.70%+29.99
TrackBofASec 94.03 09/22/06 Outperform NS $26.17-23.92%+6.70%-30.62
Track2006Wired40 97.89 06/27/06 Outperform 1Y $21.15-5.86%+13.39%-19.25

Results 1 - 21 of 21  

Beat this Stock

Clicking "Beat this Stock!" will bring you to a company with a higher rating than the one you're currently viewing.

Even though CAPS shows only one- to five-star rankings, behind the scenes, all companies in CAPS have a distinct numerical ranking. In other words, there is a No. 1 stock in CAPS and a worst-ranked stock in CAPS. When you arrive at the top-ranked stock, clicking "Beat this Stock!" will cause the page to refresh.

That is, until there is a new No. 1 stock!

These companies do not represent formal Motley Fool recommendations. Please do your own due diligence before investing. Fool on.